Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.

The latest health news includes a call by former President Trump for Congress to update laws to ensure access to CBD products, global medical concerns like bird flu leading to import bans, innovations ...

U.S. ⁠President Donald ​Trump ‌in ‌a ⁠Truth Social ⁠post on Thursday ​called ​on ⁠Congress ⁠to ⁠update the law ​to ​ensure ...

Long associated with the relief of certain symptoms, cannabidiol (CBD), which has no psychoactive effect, is generating ...

The government recently loosened medical marijuana rules. Experts separate fact from fiction about the drug’s safety and ...

The reclassification of cannabis as a Schedule III substance is meant to remove barriers for researchers but its effects ...

The team developed a stretchy, hemp-derived thermoplastic that is capable of extending up to 1,600% of its size. Thanks to ...

For investors, a shift in FDA policy [represents] a tectonic move for the valuation of legacy tobacco and specialized vaping firms.”Few ...

Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain development.

A team of American scientists and engineers have developed a stretchy, hemp-derived thermoplastic that can extend up to 1,600 ...

The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while ...

Those of you who have been following along with our series on marijuana rescheduling know that on April 22, 2026, the DEA issued its ...